Literature DB >> 23546992

TOMM40 polymorphisms in Italian Alzheimer's disease and frontotemporal dementia patients.

Silvia Bagnoli1, Irene Piaceri, Andrea Tedde, Valentina Bessi, Laura Bracco, Sandro Sorbi, Benedetta Nacmias.   

Abstract

Chromosome 19 is one of the several prominent chromosomes related to the risk of developing late-onset Alzheimer's disease (LOAD) and frontotemporal lobar degeneration (FTLD). However, only Apolipoprotein E (APOE) has been confirmed as a risk factor for both disorders. The aim of this study was to investigate a set of polymorphisms in the translocase of the outer mitochondrial membrane 40 (TOMM40) gene, located in close proximity to APOE, to clarify if the TOMM40 gene may be considered a risk factor for AD and FTLD, independently of APOE status. We performed a case-control study in a dataset of Italian LOAD and FTLD patients, analyzing the following three single-nucleotide polymorphisms (SNPs): rs157580, rs2075650 and rs157581. The analysis was made in 710 Italian subjects: 282 LOAD patients, 156 FTLD patients and 272 healthy subjects. Our results confirm the presence of an association between TOMM40 SNPs and LOAD in our Italian population, suggesting that genetic variations proximate to APOE contributes to the LOAD risk. Genotype and allele distribution of the TOMM40 polymorphisms between the FTLD group and controls did not show any statistical difference. When we analyzed haplotype distribution of the SNPs, taking into account the presence of the APOE allele, we observed a strong association between the ε4 allele and the GAC haplotype both in LOAD and FTLD patients. In contrast, this association did not hold for ε3/GAC. These results demonstrate that the TOMM40 gene does not have an APOE-independent role in the risk of developing LOAD and FTLD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23546992     DOI: 10.1007/s10072-013-1425-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  9 in total

Review 1.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.

Authors:  D Neary; J S Snowden; L Gustafson; U Passant; D Stuss; S Black; M Freedman; A Kertesz; P H Robert; M Albert; K Boone; B L Miller; J Cummings; D F Benson
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

2.  Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice.

Authors:  Della C David; Susanne Hauptmann; Isabel Scherping; Katrin Schuessel; Uta Keil; Patrizia Rizzu; Rivka Ravid; Stefan Dröse; Ulrich Brandt; Walter E Müller; Anne Eckert; Jürgen Götz
Journal:  J Biol Chem       Date:  2005-04-14       Impact factor: 5.157

3.  TOMM40, APOE, and APOC1 in primary progressive aphasia and frontotemporal dementia.

Authors:  Davide Seripa; Alessandra Bizzarro; Andrea Pilotto; Orazio Palmieri; Francesco Panza; Grazia D'Onofrio; Carolina Gravina; Silvana Archetti; Antonio Daniele; Barbara Borroni; Alessandro Padovani; Carlo Masullo
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration.

Authors:  Daniela Galimberti; Elio Scarpini
Journal:  Int J Clin Exp Med       Date:  2010-05-15

5.  Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease.

Authors:  G M McKhann; M S Albert; M Grossman; B Miller; D Dickson; J Q Trojanowski
Journal:  Arch Neurol       Date:  2001-11

6.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.

Authors:  Denise Harold; Richard Abraham; Paul Hollingworth; Rebecca Sims; Amy Gerrish; Marian L Hamshere; Jaspreet Singh Pahwa; Valentina Moskvina; Kimberley Dowzell; Amy Williams; Nicola Jones; Charlene Thomas; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Clive Holmes; David Mann; A David Smith; Seth Love; Patrick G Kehoe; John Hardy; Simon Mead; Nick Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Britta Schürmann; Reinhard Heun; Hendrik van den Bussche; Isabella Heuser; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Kristel Sleegers; Karolien Bettens; Sebastiaan Engelborghs; Peter P De Deyn; Christine Van Broeckhoven; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panagiotis Deloukas; Ammar Al-Chalabi; Christopher E Shaw; Magda Tsolaki; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; Peter A Holmans; Michael O'Donovan; Michael J Owen; Julie Williams
Journal:  Nat Genet       Date:  2009-09-06       Impact factor: 38.330

7.  A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.

Authors:  Russell H Swerdlow; Shaharyar M Khan
Journal:  Med Hypotheses       Date:  2004       Impact factor: 1.538

8.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  A genome-wide association study for late-onset Alzheimer's disease using DNA pooling.

Authors:  Richard Abraham; Valentina Moskvina; Rebecca Sims; Paul Hollingworth; Angharad Morgan; Lyudmila Georgieva; Kimberley Dowzell; Sven Cichon; Axel M Hillmer; Michael C O'Donovan; Julie Williams; Michael J Owen; George Kirov
Journal:  BMC Med Genomics       Date:  2008-09-29       Impact factor: 3.063

  9 in total
  13 in total

1.  Correlations Between Single Nucleotide Polymorphisms, Cognitive Dysfunction, and Postmortem Brain Pathology in Alzheimer's Disease Among Han Chinese.

Authors:  Qian Yang; Kang Chen; Hanlin Zhang; Wanying Zhang; Changlin Gong; Qing Zhang; Pan Liu; Tianyi Sun; Yuanyuan Xu; Xiaojing Qian; Wenying Qiu; Chao Ma
Journal:  Neurosci Bull       Date:  2019-02-19       Impact factor: 5.203

2.  APOE, TOMM40, and sex interactions on neural network connectivity.

Authors:  Tianqi Li; Colleen Pappas; Scott T Le; Qian Wang; Brandon S Klinedinst; Brittany A Larsen; Amy Pollpeter; Ling Yi Lee; Mike W Lutz; William K Gottschalk; Russell H Swerdlow; Kwangsik Nho; Auriel A Willette
Journal:  Neurobiol Aging       Date:  2021-09-30       Impact factor: 4.673

3.  Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.

Authors:  Anatoliy I Yashin; Fang Fang; Mikhail Kovtun; Deqing Wu; Matt Duan; Konstantin Arbeev; Igor Akushevich; Alexander Kulminski; Irina Culminskaya; Ilya Zhbannikov; Arseniy Yashkin; Eric Stallard; Svetlana Ukraintseva
Journal:  Exp Gerontol       Date:  2017-10-26       Impact factor: 4.032

4.  Genetics of Human Longevity From Incomplete Data: New Findings From the Long Life Family Study.

Authors:  Anatoliy I Yashin; Konstantin G Arbeev; Deqing Wu; Liubov S Arbeeva; Olivia Bagley; Eric Stallard; Alexander M Kulminski; Igor Akushevich; Fang Fang; Mary K Wojczynski; Kaare Christensen; Anne B Newman; Robert M Boudreau; Michael A Province; Stephen Thielke; Thomas T Perls; Ping An; Irma Elo; Svetlana V Ukraintseva
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-10-08       Impact factor: 6.053

5.  TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population.

Authors:  Zheng Zhu; Yang Yang; Zhenxu Xiao; Qianhua Zhao; Wanqing Wu; Xiaoniu Liang; Jianfeng Luo; Yang Cao; Minhua Shao; Qihao Guo; Ding Ding
Journal:  Aging Clin Exp Res       Date:  2020-07-28       Impact factor: 3.636

6.  Polymorphisms of genes involved in lipid metabolism and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC study.

Authors:  Asahi Hishida; Kenji Wakai; Mariko Naito; Shino Suma; Tae Sasakabe; Nobuyuki Hamajima; Satoyo Hosono; Mikako Horita; Tanvir Chowdhury Turin; Sadao Suzuki; Tara Sefanya Kairupan; Haruo Mikami; Keizo Ohnaka; Isao Watanabe; Hirokazu Uemura; Michiaki Kubo; Hideo Tanaka
Journal:  Lipids Health Dis       Date:  2014-10-14       Impact factor: 3.876

7.  Associations Between Genetic Variants in 19p13 and 19q13 Regions and Susceptibility to Alzheimer Disease: A Meta-Analysis.

Authors:  Jie Bao; Xiao-jie Wang; Zong-fu Mao
Journal:  Med Sci Monit       Date:  2016-01-22

8.  Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration.

Authors:  Wen-Hua Su; Zhi-Hong Shi; Shu-Ling Liu; Xiao-Dan Wang; Shuai Liu; Yong Ji
Journal:  Oncotarget       Date:  2017-07-04

9.  Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish Population.

Authors:  J A Monge-Argilés; R Gasparini-Berenguer; M Gutierrez-Agulló; C Muñoz-Ruiz; J Sánchez-Payá; C Leiva-Santana
Journal:  Biomed Res Int       Date:  2016-03-22       Impact factor: 3.411

10.  A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia.

Authors:  Raffaele Ferrari; Mario Grassi; Erika Salvi; Barbara Borroni; Fernando Palluzzi; Daniele Pepe; Francesca D'Avila; Alessandro Padovani; Silvana Archetti; Innocenzo Rainero; Elisa Rubino; Lorenzo Pinessi; Luisa Benussi; Giuliano Binetti; Roberta Ghidoni; Daniela Galimberti; Elio Scarpini; Maria Serpente; Giacomina Rossi; Giorgio Giaccone; Fabrizio Tagliavini; Benedetta Nacmias; Irene Piaceri; Silvia Bagnoli; Amalia C Bruni; Raffaele G Maletta; Livia Bernardi; Alfredo Postiglione; Graziella Milan; Massimo Franceschi; Annibale A Puca; Valeria Novelli; Cristina Barlassina; Nicola Glorioso; Paolo Manunta; Andrew Singleton; Daniele Cusi; John Hardy; Parastoo Momeni
Journal:  Neurobiol Aging       Date:  2015-06-12       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.